Weight-loss injections: ‘Two years ago I had to use a mobility scooter, this year I am hiking’
High costs are a common worry among users of Ozempic, Mounjaro and other weight-loss drugs, who report varying levels of success
obesity
stories related to people with obesity
‘Obesity medications may not make you thin or happy but they will improve your health’
GLP-1 drugs need to be reframed in the public mind as an essential medical treatment rather than ‘skinny jabs’, say practitioners
The drivers of obesity that also come with climate impacts
Thinking in a Climate Emergency: ultraprocessed foods are a leading cause of rising rates of obesity
Eli Lilly’s weight-loss breakthroughs face brutal investor scrutiny
Perfection was priced in, anything less provoked panic as shares were hit with worst one-day drop in 25 years
Eli Lilly obesity pill disappoints in trial, sending shares down 14%
Weight loss comes in at lower end of expectations and triggers stock boost for rival Novo Nordisk
Liver cancer: ‘The saddest part is that most of the cases are preventable’
On current trends, number of new annual diagnoses will almost double by 2050
Novo Nordisk cuts sales forecasts on lower US demand for obesity drug
First-quarter sales rise 18 per cent but Danish pharma group blames custom preparations at pharmacies for weaker take-up
Pfizer’s Irish staff fear for jobs as drugmaker seeks another €1.5bn in cuts
Pharma giant now looking for $7.7bn in annual savings by 2027 as it grapples with falling post-Covid sales and lack of new blockbusters
Lilly’s weight loss pill is a ‘landmark moment’ in the obesity fight
Prof Donal O’Shea hails breakthrough and says it may play key role in reshaping treatments
Weight loss drug Wegovy to cost around €220 a month as supplies go on market in Ireland
Weight loss drug is not yet approved for reimbursement under Drug Payment Scheme or for medical card patients
Generic drugmaker races to launch versions of blockbuster obesity drugs
Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year
Novo Nordisk to explore how obesity drugs can help patients with addiction
Danish obesity drug giant looking at whether its semaglutide drug can reduce cravings associated with addiction
More than half of adults will be obese or overweight by 2050, study finds
Spiralling rates of people who are obese and overweight a ‘monumental societal failure’
Insurers will not cover obesity drugs that will cost users €2,500-plus a year
Patients looking to access Eli Lilly’s Mounjaro from next week will have to pay privately
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
The GlossOpens in new window
Read the digital edition of The Gloss magazine now
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices